These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24969453)

  • 1. [Economic evaluation of needle and syringe exchange in two provinces of Southwest China].
    Xue H; Hu Y; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):291-5. PubMed ID: 24969453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
    Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
    Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program.
    Harris ZK
    Health Econ; 2006 Feb; 15(2):147-58. PubMed ID: 16145716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
    Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
    AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
    Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
    Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.
    Nguyen TQ; Weir BW; Des Jarlais DC; Pinkerton SD; Holtgrave DR
    AIDS Behav; 2014 Nov; 18(11):2144-55. PubMed ID: 24824043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M; Wodak A; Conigrave KM
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
    Iversen J; Topp L; Wand H; Maher L
    Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.
    Cao W; Treloar C
    Drug Alcohol Rev; 2006 Sep; 25(5):439-44. PubMed ID: 16939939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Needle and syringe programs in Yunnan, China yield health and financial return.
    Zhang L; Yap L; Xun Z; Wu Z; Wilson DP
    BMC Public Health; 2011 Apr; 11():250. PubMed ID: 21507267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.
    Hancock E; Ward Z; Ayres R; Neale J; Hussey D; Kesten JM; Hickman M; Vickerman P
    Addiction; 2020 Apr; 115(4):702-713. PubMed ID: 31633849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.